R03DX08 reslizumab
ATC group of level 5 – chemical substance · in plain English: tablets for asthma and COPD
This site has the patient leaflet or the SPC of 2 medicines in this group.
Place in the ATC classification
- R Respiratory system drugs 803 medicines
- R03 Drugs for obstructive airway diseases 396 medicines
- R03D Other systemic drugs for obstructive airway diseases 60 medicines
- R03DX Other systemic drugs for obstructive airway diseases 25 medicines
- R03DX08 reslizumab 2 medicines
- R03DX Other systemic drugs for obstructive airway diseases 25 medicines
- R03D Other systemic drugs for obstructive airway diseases 60 medicines
- R03 Drugs for obstructive airway diseases 396 medicines
Active substances in the group
- Reslizumab 1 medicine
- Roflumilast 1 medicine
Medicines
| Medicine | Legal category |
|---|---|
| Cinqaero 10 mg / ml concentrate for solution for infusion SPC | – |
| Libertek SPC | – |
Other groups of the same level
- R03DX05 omalizumab 12 medicines
- R03DX07 roflumilast 5 medicines
- R03DX09 mepolizumab 4 medicines
- R03DX10 benralizumab 2 medicines
Other names of the ATC group
- Czech: R03DX08 Reslizumab
- German: R03DX08 Reslizumab
- German: R03DX08 Reslizumab
- Italian: R03DX08 RESLIZUMAB
- Polish: R03DX08 RESLIZUMAB
- Turkish: R03DX08 reslizumab
- Portuguese (Brazil): R03DX08 Reslizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group R03DX08
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.